Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × 1-dodecylpyridoxal × Clear all

NCT04983550 2021-07-30

Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms